Plunkett Research Online: Arch Biopartners, Inc.

ARCH BIOPARTNERS, INC. (ARCH:TSX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Arch Biopartners Inc is a clinical stage company developing technologies with the potential to make medical or commercial impacts. The company is developing a drug platform Metablok to produce drug candidates to inhibit organ inflammation caused via the DPEP-1 pathway. Its under development portfoli.....



Arch Biopartners, Inc.
Ticker: ARCH
Exchange: TSX
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 647 428-7031
Fax: 647 428-7032
Address: 27 St. Clair Avenue East
P.O. Box 305
Toronto, ON M4T 2M5 Canada

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Computer Software (Business and Consumer), Packaged Software, Artificial Intelligence (AI), Software as a Service (Saas) Industry
Contacts Description

Richard Muruve CEO/Director/President/Co-Founder
Andrew Bishop CFO/Director
See More
Arch Biopartners Inc is a clinical stage company developing technologies with the potential to make medical or commercial impacts. The company is developing a drug platform Metablok to produce drug candidates to inhibit organ inflammation caused via the DPEP-1 pathway. Its under development portfoli.....See More See More

Auditor: The Exchange LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
2019 2018 2017 2016 2015 2014
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: